WallStreetZenWallStreetZen

NASDAQ: VYGR
Voyager Therapeutics Inc Stock Ownership - Who owns Voyager Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Voyager Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Alfred SandrockPresident and CEO2024-04-0212,115$9.86
$119.45kSell
Robin SwartzChief Operating Officer2024-04-021,357$9.88
$13.41kSell
Todd Alfred CarterChief Scientific Officer2024-02-213,365$7.47
$25.14kSell
Peter P. PfreundschuhChief Financial Officer2024-02-213,764$7.46
$28.08kSell
Alfred SandrockPresident and CEO2024-02-2113,033$7.46
$97.23kSell
Robin SwartzChief Operating Officer2024-02-213,966$7.45
$29.55kSell
Todd Alfred CarterChief Scientific Officer2024-02-20602$7.68
$4.62kSell
Todd Alfred CarterChief Scientific Officer2024-01-171,266$7.18
$9.09kSell
Robin SwartzChief Operating Officer2024-01-172,543$7.15
$18.18kSell
Peter P. PfreundschuhChief Financial Officer2023-10-0313,567$6.99
$94.83kSell

1 of 2

VYGR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VYGR insiders and whales buy or sell their stock.

VYGR Shareholders

What type of owners hold Voyager Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Neurocrine Biosciences Inc15.79%8,575,316$66.37MInsider
Ecor1 Capital LLC14.97%8,128,014$62.91MInsider
Mark J. Levin11.84%6,427,874$49.75MInsider
Armistice Capital LLC7.80%4,236,000$32.79MInstitution
Ecor1 Capital LLC7.09%3,851,507$29.81MInstitution
Blackrock Inc4.85%2,632,679$20.38MInstitution
Vanguard Group Inc4.66%2,529,668$19.58MInstitution
Sanofi4.56%2,477,941$19.18MInsider
Farallon Capital Management LLC2.38%1,292,000$10.00MInstitution
Price T Rowe Associates Inc1.85%1,004,786$7.78MInstitution

1 of 3

VYGR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VYGR47.14%52.86%Net SellingNet Selling
CDMO90.48%9.09%Net Selling
HRTX48.57%51.43%Net Buying
LRMR42.05%57.95%Net BuyingNet Buying
NGNE36.48%63.52%Net Buying
View Top Biotech Stocks

Voyager Therapeutics Stock Ownership FAQ

Who owns Voyager Therapeutics?

Voyager Therapeutics (NASDAQ: VYGR) is owned by 47.69% institutional shareholders, 53.47% Voyager Therapeutics insiders, and 0.00% retail investors. Neurocrine Biosciences Inc is the largest individual Voyager Therapeutics shareholder, owning 8.58M shares representing 15.79% of the company. Neurocrine Biosciences Inc's Voyager Therapeutics shares are currently valued at $64.74M.

If you're new to stock investing, here's how to buy Voyager Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.